As of 2025-05-05, the Relative Valuation of INmune Bio Inc (INMB) is (13.69) USD. This relative valuation is based on P/E multiples. With the latest stock price at 7.76 USD, the upside of INmune Bio Inc based on Relative Valuation is -276.4%.
The range of the Relative Valuation is (1.28) - (25.27) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 0.7x - 14.8x | 7.8x |
| Forward P/E multiples | 0.6x - 13.8x | 7.2x |
| Fair Price | (1.28) - (25.27) | (13.69) |
| Upside | -116.5% - -425.7% | -276.4% |
| Date | P/E |
| 2025-04-28 | -4.31 |
| 2025-04-25 | -4.27 |
| 2025-04-24 | -4.39 |
| 2025-04-23 | -4.50 |
| 2025-04-22 | -4.28 |
| 2025-04-21 | -3.98 |
| 2025-04-17 | -4.00 |
| 2025-04-16 | -3.99 |
| 2025-04-15 | -4.08 |
| 2025-04-14 | -4.13 |
| 2025-04-11 | -4.03 |
| 2025-04-10 | -3.68 |
| 2025-04-09 | -4.17 |
| 2025-04-08 | -3.74 |
| 2025-04-07 | -3.99 |
| 2025-04-04 | -3.97 |
| 2025-04-03 | -4.24 |
| 2025-04-02 | -4.41 |
| 2025-04-01 | -4.14 |
| 2025-03-31 | -4.26 |
| 2025-03-28 | -4.11 |
| 2025-03-27 | -4.05 |
| 2025-03-26 | -4.22 |
| 2025-03-25 | -4.84 |
| 2025-03-24 | -4.53 |
| 2025-03-21 | -4.43 |
| 2025-03-20 | -4.45 |
| 2025-03-19 | -4.54 |
| 2025-03-18 | -3.93 |
| 2025-03-17 | -4.19 |
| 2025-03-14 | -4.34 |
| 2025-03-13 | -4.39 |
| 2025-03-12 | -4.79 |
| 2025-03-11 | -4.46 |
| 2025-03-10 | -4.34 |
| 2025-03-07 | -4.38 |
| 2025-03-06 | -4.38 |
| 2025-03-05 | -4.47 |
| 2025-03-04 | -4.42 |
| 2025-03-03 | -4.23 |
| 2025-02-28 | -4.38 |
| 2025-02-27 | -4.29 |
| 2025-02-26 | -4.26 |
| 2025-02-25 | -4.18 |
| 2025-02-24 | -4.37 |
| 2025-02-21 | -4.69 |
| 2025-02-20 | -4.96 |
| 2025-02-19 | -5.18 |
| 2025-02-18 | -5.01 |
| 2025-02-14 | -5.01 |